NOVADOZ PHARMACEUTICALS supplier risk profile and Q1-2026 trade data analysis
NOVADOZ PHARMACEUTICALS imported 86 shipments in Q1 2026 across 2 suppliers, all originating from India. The company's sourcing is highly concentrated, with 100% of shipments sourced from a single country. MSN LABORATORIES and MSN LABORATORIES PRIVATE are the sole suppliers, with MSN LABORATORIES accounting for 82 of the 86 shipments. The import portfolio spans HS Chapter 30 (pharmaceutical products) and HS Chapter 39 (plastics and articles thereof).
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
One name matching sanctions watchlists was detected in the company's import footprint. No suppliers registered exposure to Uyghur Forced Labor Prevention Act (UFLPA) restricted entities based on available supply-chain visibility data.
2 distinct tier-1 suppliers in Q1 2026
| MSN LABORATORIES | India | 82 |
| MSN LABORATORIES PRIVATE | India | 4 |
Share of Q1 2026 inbound shipments by source country
1 tier-2 + 1 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.